Inventor · disambiguated record
Robert L. Bratzler
Also filed as: BRATZLER ROBERT L
6 granted patents·19 pending applications·319 citations·filing 1990–2018
86Inventor score
Files withCOLEY PHARM GROUP INC5UNIV IOWA RES FOUND3BRATZLER ROBERT L2COLEY PHARM GMBH2MANISTEE PARTNERS LLC2
Top patents by PatentIndex Score
25 records- 0197US6949520B1Methods related to immunostimulatory nucleic acid-induced interferonCOLEY PHARM GMBH·Filed 2000·Granted Sep 27, 2005·165 cites·89 claims
- 0296US7776344B2Methods related to immunostimulatory nucleic acid-induced interferonUNIV IOWA RES FOUND·Filed 2005·Granted Aug 17, 2010·53 cites·9 claims
- 0392US7585847B2Immunostimulatory nucleic acids for the treatment of asthma and allergyCOLEY PHARM GROUP INC·Filed 2001·Granted Sep 8, 2009·76 cites·21 claims
- 0465US2009155212A1Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancerBRATZLER ROBERT L·Filed 2008·Application pending·0 cites
- 0564US2007037767A1Immunostimulatory nucleic acids for the treatment of asthma and allergyCOLEY PHARM GROUP INC·Filed 2006·Application pending·0 cites
- 0662US2006154890A1Immunostimulatory nucleic acids for the treatment of asthma and allergyCOLEY PHARM GROUP INC·Filed 2005·Application pending·0 cites
- 0761US9913849B2Treatment of migrainesMANISTEE PARTNERS LLC·Filed 2015·Granted Mar 13, 2018·1 cites·8 claims
- 0859US2004235774A1Immunostimulatory nucleic acids for the treatment of asthma and allergyFiled 2004·Application pending·0 cites
- 0958US5167824ASeparation by carrier mediated transportCREATIVE BIOMOLECULES INC·Filed 1990·Granted Dec 1, 1992·24 cites·12 claims
- 1056US2011033421A1Methods related to immunostimulatory nucleic acid-induced interferonCOLEY PHARM GMBH·Filed 2010·Application pending·0 cites
- 1156US2005169888A1Methods related to immunostimulatory nucleic acid-induced interferonUNIV IOWA RES FOUND·Filed 2005·Application pending·0 cites
- 1255US2017349433A1Immunonanotherapeutics providing a th1-biased responseLIPFORD GRAYSON B·Filed 2017·Application pending·0 cites
- 1354US2006211639A1Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancerBRATZLER ROBERT L·Filed 2003·Application pending·0 cites
- 1453US10363258B2Treatment of migrainesMANISTEE PARTNERS LLC·Filed 2018·Granted Jul 30, 2019·0 cites·23 claims
- 1550US2006188913A1Methods and products for enhancing immune responses using imidazoquinoline compoundsCOLEY PHARM GROUP INC·Filed 2006·Application pending·0 cites
- 1648US2002156033A1Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancerFiled 2001·Application pending·0 cites
- 1747US2003139364A1Methods and products for enhancing immune responses using imidazoquinoline compoundsUNIV IOWA RES FOUND·Filed 2002·Application pending·0 cites
- 1846US2010189772A1Compositions of TLR ligands and antiviralsCOLEY PHARM GROUP INC·Filed 2007·Application pending·0 cites
- 1943US2011223201A1Immunonanotherapeutics Providing a Th1-Biased ResponseSELECTA BIOSCIENCES INC·Filed 2010·Application pending·0 cites
- 2043US2004131628A1Nucleic acids for the treatment of disorders associated with microorganismsFiled 2003·Application pending·0 cites
- 2140US2019313934A1Device and system for monitoring and treating muscle tension-related medical conditionsBIOTRAK HEALTH INC·Filed 2017·Application pending·0 cites
- 2240US2002198165A1Nucleic acids for the prevention and treatment of gastric ulcersFiled 2001·Application pending·0 cites
- 2338US2002165178A1Immunostimulatory nucleic acids for the treatment of anemia, thrombocytopenia, and neutropeniaFiled 2001·Application pending·0 cites
- 2438US2003055014A1Inhibition of angiogenesis by nucleic acidsFiled 2001·Application pending·0 cites
- 2534US2002091097A1Nucleic acids for the prevention and treatment of sexually transmitted diseasesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert L. Bratzler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →